Top Abstract Purchase Related
Home
>
Node
>
Subnode

Indian kala-azar--better tools needed for diagnosis and treatment

Sundar, S.

Journal of Postgraduate Medicine 49(1): 29-30

2003

ISSN/ISBN: 0022-3859
PMID: 12865568
Document Number: 264337
This paper outlines currently available options for the diagnosis and treatment of kala azar (visceral leishmaniasis) in India. Currently used diagnostic techniques include splenic or bone marrow aspiration, serodiagnostic tests (i.e., ELISA, direct agglutination test, immunochromatographic test), antigen detection, and DNA detection with polymerase chain reaction. Treatment options include the use of pentavalent antimonial compounds, pentamidine, liposomal amphotericin B, paromomycin, sitamaquine and miltefosine.

Document emailed within 1 workday
Secure & encrypted payments

Mayrink, W.; Magalhàes, P.A.; Batista, S.M.; da Costa, C.A. 1971: Diagnosis of kala-azar. II. Study of Montenegro's test and detection of Leishmania in skin material from patients with kala-azar, before and after antimony treatment Revista do Instituto de Medicina Tropical de Sao Paulo 13(4): 268-271
Sultana, A.; Zakaria, S.M.; Bhuiyan, S.I.; Habib, A.; Dey, S.K.; Rahman, M.; Basher, A. 2012: Spectrum of skin lesions of post-kala-azar dermal leishmaniasis in kala-azar endemic areas of Bangladesh Mymensingh Medical Journal: Mmj 21(3): 529-532
Sharma, V.K.; Jha, T.K. 1986: Recurrence of Kala-azar in a Case of Post Kala-azar Dermal Leishmaniasis Indian Journal of Dermatology Venereology and Leprology 52(1): 46-47
Talukdar, B.; Kanwar, A.; Saini, L.; Singh, T.; Chauhan, S. 1987: Lymphadenopathy in Indian kala-azar Indian Pediatrics 24(11): 1043-1045
Ranjan, A.; Sur, D.; Singh, V.P.; Siddique, N.A.; Manna, B.; Lal, C.S.; Sinha, P.K.; Kishore, K.; Bhattacharya, S.K. 2005: Risk factors for Indian kala-azar American Journal of Tropical Medicine and Hygiene 73(1): 74-78
Sacks, D.L.; Lal, S.L.; Shrivastava, S.N.; Blackwell, J.; Neva, F.A. 1987: An analysis of T cell responsiveness in Indian kala-azar Journal of Immunology 138(3): 908-913
Mondal, D.; Hasnain, M.G.; Hossain, M.S.; Ghosh, D.; Ghosh, P.; Hossain, H.; Baker, J.; Nath, R.; Haque, R.; Matlashewski, G.; Hamano, S. 2016: Study on the safety and efficacy of miltefosine for the treatment of children and adolescents with post-kala-azar dermal leishmaniasis in Bangladesh, and an association of serum vitamin E and exposure to arsenic with post-kala-azar dermal leishmaniasis: an open clinical trial and case-control study protocol Bmj Open 6(5): E010050
Salotra, P.; Raina, A.; Negi, N.S. 1999: Immunoblot analysis of the antibody response to antigens of Leishmania donovani in Indian kala-azar British Journal of Biomedical Science 56(4): 263-267
Singh S; Kumar, J.; Singh, R.; Dwivedi, S.N. 2000: Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 4(4): 203-208
Basu, D.; Mukherjee, H.; Hati, A.K. 1995: New problem in diagnosis of kala-azar Journal of the Indian Medical Association 93(3): 115-116
Thakur, C.P.; Sinha, G.P.; Sharma, V.; Barat, D. 1993: The treatment of kala-azar during pregnancy National Medical Journal of India 6(6): 263-265
Laroche, R.; Sirol, J.; Poli, L. 1978: Treatment of visceral leishmaniasis or kala-azar Medecine Tropicale: Revue du Corps de Sante Colonial 38(4): 401-404
Peters, W. 1981: The treatment of kala-azar--new approaches to an old problem Indian Journal of Medical Research 73(Suppl): 1-18
Ahsan, M.M.; Islam, M.N.; Mollah, A.H.; Hoque, M.A.; Hossain, M.A.; Begum, Z.; Islam, M.T. 2010: Evaluation of latex agglutination test (KAtex) for early diagnosis of kala-azar Mymensingh Medical Journal: Mmj 19(3): 335-339
Nyakundi, P.M.; Rashid, J.R.; Wasunna, K.M.; Were, J.B.; Muigai, R.; Kirigi, G.; Mbugua, J. 1995: Problems in the treatment of kala-azar: case report East African Medical Journal 72(6): 406-408
Sundar, S.; Murray, H.W. 2005: Availability of miltefosine for the treatment of kala-azar in India Bulletin of the World Health Organization 83(5): 394-395
Karki, P.; Koirala, S.; Parija, S.C.; Hansdak, S.G.; Das, M.L. 1998: A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal Southeast Asian Journal of Tropical Medicine and Public Health 29(1): 154-158
Thakur, C.P.; Kumar, A.; Mitra, G.; Thakur, S.; Sinha, P.K.; Das, P.; Bhattacharya, S.K.; Sinha, A. 2008: Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India Indian Journal of Medical Research 128(1): 38-44
Murray, H.W. 2000: Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 4(3): 158-177
Hörder, M.; Vanek, E.; Heymer, B. 1979: Kala-azar acquired in Europe: a case report with particular consideration of its epidemiology and treatment Die Medizinische Welt 30(8): 280-284